![Peter Fernandes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Fernandes
Vorsitzender bei
The Pulmonary Vascular Research Institute
Profil
Peter Fernandes is currently the Co-Chairman at The Pulmonary Vascular Research Institute.
He previously worked as the Vice President-Global Regulatory Affairs at Ikaria, Inc. from 2012 to 2015, Head-Regulatory Affairs & Quality Assurance at OptiNose, Inc. from 2010 to 2012, VP-Regulatory Affairs & Quality Assurance at ALTANA Pharma US, Inc. from 2005 to 2007, and Vice President-US Drug Regulatory Affairs at Novartis Pharmaceuticals AG from 2007 to 2010.
He is also currently the Chief Executive, Financial & Accounting Officer at Bellerophon Therapeutics, Inc. starting from 2015.
Mr. Fernandes received his graduate degree from The Grant Government Medical College in 1982 and his undergraduate degree from Principal K.
M.
Kundnani College of Pharmacy.
Aktive Positionen von Peter Fernandes
| Unternehmen | Position | Beginn |
|---|---|---|
The Pulmonary Vascular Research Institute
 The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as a global medical research charity | Vorsitzender | - |
Ehemalige bekannte Positionen von Peter Fernandes
| Unternehmen | Position | Ende |
|---|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Vorstandsvorsitzender | 15.11.2023 |
| IKARIA, INC. | General Counsel | 01.05.2015 |
| OPTINOSE, INC. | General Counsel | 01.09.2012 |
Novartis Pharmaceuticals AG | Corporate Officer/Principal | 01.10.2010 |
ALTANA Pharma US, Inc.
 ALTANA Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets respiratory and gastrointestinal products | General Counsel | 01.10.2007 |
Ausbildung von Peter Fernandes
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
28
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Ikaria, Inc.
 Ikaria, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics | Health Technology |
OptiNose, Inc.
 OptiNose, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for patients treated by ear, nose, throat and allergy diseases | Health Technology |
Bellerophon Therapeutics, Inc.
 Bellerophon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products to treat cardiopulmonary diseases | Health Technology |
ALTANA Pharma US, Inc.
ALTANA Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets respiratory and gastrointestinal products | Health Technology |
The Pulmonary Vascular Research Institute
The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as a global medical research charity | Commercial Services |
The Grant Government Medical College
 The Grant Government Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Principal K. M. Kundnani College of Pharmacy
 Principal K. M. Kundnani College of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals AG |
Wählen Sie MarketScreener 
